Beginning in mid-February 2008, the 1997-2007 online version of the Science Watch® newsletter, ESI-Topics.com, and in-cites.com, will all be featured together on the redesigned ScienceWatch.com. All previous content from the three sites will be permanently archived, and remain accessible from any existing bookmarks to the archived pages. No new content will be added to this site. Updates and new content (updated biweekly) are available at ScienceWatch.com now.
Thomson
Essential Science Indicators - Special Topics  RSS feeds for the editorial Web sites of Essential Science Indicators.
All Topics Menu
|  Previous Page  |  |  Special Topics Menu  |  |  Next Page  |      Help || About || Contact

•> Search Special Topics
Polybrominated Diphenyl Ethers Menu

ESI Special Topic: Polybrominated Diphenyl Ethers
Publication Date: August 2007

Polybrominated Diphenyl Ethers

ESI Special Topics: August 2007
Citing URL: http://esi-topics.com/pbde/interviews/RF-ArnoldSchecter.html

A Research Front Map INTERVIEW with Dr. Arnold Schecter
 

<• Return to Research Front Map

Dr. Arnold Schecter’s paper, "Polybrominated diphenyl ethers (PBDEs) in US mothers’ milk" (Environ. Health Perspect. 111[14]: 1723-9, Nov. 2003) is a core paper in the Brominated Flame Retardants in the Environment Research Front, which is part of our Special Topic on PBDE research over the past decade. According to Essential Science IndicatorsSM, this paper has been cited 79 times to date. Dr. Schecter’s record in our database includes 22 original articles and papers published over the past decade in the field of Environment & Ecology, which have been cited a total of 383 times to date. Dr. Schecter is a Professor of Environmental Sciences at the University of Texas School of Public Health in Dallas. In the interview below, he answers a few questions about his highly cited paper.

ST:  Would you please describe the significance of your paper and why it is highly cited?


“The unexpected finding of very high levels of these persistent, toxic, synthetic chemicals in humans may constitute a public health threat...”

This was the first paper published in a scientific journal to document that:

  1. All US human milk samples studied were contaminated with PBDEs, a toxic brominated flame retardant.
  2. These levels were the highest in the world, 10-30 times higher than European levels. US total PBDE levels were usually between 4 and 400+ parts per billion (ppb), lipid, in these milk samples.
  3. We measured up to 13 congeners in these milk samples.

ST:  How did you become involved in this research, and were there any particular successes or obstacles that stand out?

A short time before, Swedish researchers noted that in Sweden, PBDEs were increasing exponentially over time in human breast milk while at the same time other persistent organic pollutants such as dioxins and PCBs were declining.

Others later found similar findings to ours in US human milk samples. Obstacles include the difficulty in measuring BDE 209, the only one currently being manufactured, because of general contamination, including laboratory contamination, with this PBDE congener.

ST:  Where do you see your research and the broader field leading in the future?

Further studies need to be conducted to determine how much enters the body from food, and how much from dust ingestion as well as air intake.

Food levels need to be better characterized. There have only been two market-basket studies of US food to date and the data is not consistent as to levels of contamination from similar food types.

Dr. Arnold Schecter's most-cited paper represented in the Research Front map with 79 cites to date:
Schecter A, et al., "Polybrominated diphenyl ethers (PBDEs) in US mother's milk," Environ. Health Perspect. 111(14): 1723-9, November 2003. Source: Essential Science Indicators.

Human health studies need to be conducted to determine levels that may cause health damage.

Further toxicology studies need to be conducted to determine the scope of health problems which can be caused by PBDEs by themselves, by individual congeners, and as parts of mixtures with various other chemicals found in humans, including the similar PCBs.

ST:  Does your work have any social or political implications?

The unexpected finding of very high levels of these persistent, toxic, synthetic chemicals in humans may constitute a public health threat, especially in the USA with its high levels, but also in other countries. How to reduce these levels in people remains to be determined. Because of the persistence, they will remain in the environment and in people for long periods of time, even after manufacture ends.

Two of the three commercial mixtures are no longer being produced in the USA or Europe. But the third, Deca, is still in production and this may constitute an environmental and human health hazard.

On the other hand, flame and fire retardants do save lives, so attempts to reduce fire and fire damage by some means is indicated. But the brominated flame retardants may not be the best way to do this.End

Arnold Schecter, MD, MPH
University of Texas School of Public Health
Dallas, TX, USA

<• Return to Research Front Map


A Closer Look...

A closer look... Below are images sent in by Dr. Arnold Schecter which correspond with the featured paper, or current research.

Figure 1:

Figure 1: PBDEs in US human milk, percentiles, 2002, n=47 (ppb or ng/g of lipid).


Figure 2:

Figure 2: PBDEs in individual US human milk samples in rank order, 2002, (ppb or ng/g of lipid).  


Figure 3:

Figure 3: Median levels of PBDE congeners 47, 99, and 153 in human milk from different countries (ppb or ng/g of lipid).  

   

<• Return to Research Front Map
 

ESI Special Topics: August 2007
Citing URL: http://esi-topics.com/pbde/interviews/RF-ArnoldSchecter.html

•> Search Special Topics
Polybrominated Diphenyl Ethers Menu
|| All Topics Menu ||
Interview Index
Help || About || Contact

ScienceWatch.com - Tracking Trends and Perfomance in Basic Research
Go to the new ScienceWatch.com

Write to the Webmaster with questions/comments. Terms of Usage.
The Research Services Group of Thomson Scientific |
(c) 2008 The Thomson Corporation.